266 related articles for article (PubMed ID: 22763262)
1. Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study.
Itani KM; Rosen M; Vargo D; Awad SS; Denoto G; Butler CE;
Surgery; 2012 Sep; 152(3):498-505. PubMed ID: 22763262
[TBL] [Abstract][Full Text] [Related]
2. Use of human acellular dermal matrix for hernia repair: friend or foe?
Candage R; Jones K; Luchette FA; Sinacore JM; Vandevender D; Reed RL
Surgery; 2008 Oct; 144(4):703-9; discussion 709-11. PubMed ID: 18847657
[TBL] [Abstract][Full Text] [Related]
3. Comparative study between biologic porcine dermal meshes: risk factors of postoperative morbidity and recurrence.
Romain B; Story F; Meyer N; Delhorme JB; Brigand C; Rohr S
J Wound Care; 2016 Jun; 25(6):320-5. PubMed ID: 27286664
[TBL] [Abstract][Full Text] [Related]
4. The use of acellular dermal matrix for contaminated abdominal wall defects: wound status predicts success.
Schuster R; Singh J; Safadi BY; Wren SM
Am J Surg; 2006 Nov; 192(5):594-7. PubMed ID: 17071190
[TBL] [Abstract][Full Text] [Related]
5. Noncrosslinked porcine-derived acellular dermal matrix for single-stage complex abdominal wall herniorrhaphy after removal of infected synthetic mesh: a retrospective review.
Guerra O
Am Surg; 2014 May; 80(5):489-95. PubMed ID: 24887729
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Analysis of Biologic Mesh Use for Abdominal Wall Reconstruction in Clean-Contaminated and Contaminated Ventral Hernia Repair.
Sbitany H; Kwon E; Chern H; Finlayson E; Varma MG; Hansen SL
Ann Plast Surg; 2015 Aug; 75(2):201-4. PubMed ID: 24317239
[TBL] [Abstract][Full Text] [Related]
7. Indications and outcomes following complex abdominal reconstruction with component separation combined with porcine acellular dermal matrix reinforcement.
Patel KM; Nahabedian MY; Gatti M; Bhanot P
Ann Plast Surg; 2012 Oct; 69(4):394-8. PubMed ID: 22156887
[TBL] [Abstract][Full Text] [Related]
8. A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh.
Rosen MJ; Krpata DM; Ermlich B; Blatnik JA
Ann Surg; 2013 Jun; 257(6):991-6. PubMed ID: 23426340
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of surgical outcomes of retro-rectus versus intraperitoneal reinforcement with bio-prosthetic mesh in the repair of contaminated ventral hernias.
Rosen MJ; Denoto G; Itani KM; Butler C; Vargo D; Smiell J; Rutan R
Hernia; 2013 Feb; 17(1):31-5. PubMed ID: 22415440
[TBL] [Abstract][Full Text] [Related]
10. Use of a bioprosthetic mesh in complex hernia repair: early results from a French multicenter pilot study.
Lupinacci RM; Gizard AS; Rivkine E; Debove C; Menegaux F; Barrat C; Wind P; Trésallet C
Surg Innov; 2014 Dec; 21(6):600-4. PubMed ID: 24496103
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection.
Abdelfatah MM; Rostambeigi N; Podgaetz E; Sarr MG
Hernia; 2015 Feb; 19(1):135-40. PubMed ID: 24129420
[TBL] [Abstract][Full Text] [Related]
12. Use of polypropylene mesh in contaminated and dirty strangulated hernias: short-term results.
Pandey H; Thakur DS; Somashekar U; Kothari R; Agarwal P; Sharma D
Hernia; 2018 Dec; 22(6):1045-1050. PubMed ID: 30145621
[TBL] [Abstract][Full Text] [Related]
13. A modified approach to component separation using biologic graft as a load-sharing onlay reinforcement for the repair of complex ventral hernia.
Singh DP; Zahiri HR; Gastman B; Holton LH; Stromberg JA; Chopra K; Wang HD; Condé Green A; Silverman RP
Surg Innov; 2014 Apr; 21(2):137-46. PubMed ID: 23804996
[TBL] [Abstract][Full Text] [Related]
14. Non-crosslinked porcine-derived acellular dermal matrix for the management of complex ventral abdominal wall hernias: a report of 45 cases.
Guerra O; Maclin MM
Hernia; 2014 Feb; 18(1):71-9. PubMed ID: 23934355
[TBL] [Abstract][Full Text] [Related]
15. Complex Ventral Hernia Repair with Acellular Dermal Matrices: Clinical and Quality of Life Outcomes.
Roth JS; Zachem A; Plymale MA; Davenport DL
Am Surg; 2017 Feb; 83(2):141-147. PubMed ID: 28228200
[TBL] [Abstract][Full Text] [Related]
16. First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial.
Bittner JG; El-Hayek K; Strong AT; LaPinska MP; Yoo JS; Pauli EM; Kroh M
Surg Endosc; 2018 Mar; 32(3):1123-1130. PubMed ID: 28726148
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes with small intestinal submucosa for ventral abdominal hernia.
Helton WS; Fisichella PM; Berger R; Horgan S; Espat NJ; Abcarian H
Arch Surg; 2005 Jun; 140(6):549-60; discussion 560-2. PubMed ID: 15967902
[TBL] [Abstract][Full Text] [Related]
18. Acellular dermal allograft for ventral hernia repair in the compromised surgical field.
Diaz JJ; Guy J; Berkes MB; Guillamondegui O; Miller RS
Am Surg; 2006 Dec; 72(12):1181-7; discussion 1187-8. PubMed ID: 17216816
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of acute versus elective primary ventral hernia repair.
Li LT; Jafrani RJ; Becker NS; Berger RL; Hicks SC; Davila JA; Liang MK
J Trauma Acute Care Surg; 2014 Feb; 76(2):523-8. PubMed ID: 24458061
[TBL] [Abstract][Full Text] [Related]
20. Biologic mesh for repair of ventral hernias in contaminated fields: long-term clinical and patient-reported outcomes.
Madani A; Niculiseanu P; Marini W; Kaneva PA; Mappin-Kasirer B; Vassiliou MC; Khwaja K; Fata P; Fried GM; Feldman LS
Surg Endosc; 2017 Feb; 31(2):861-871. PubMed ID: 27334966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
